Long-term Safety, Tolerability and Efficacy of Alirocumab versus Placebo in 2,341 High Cardiovascular Risk Patients: ODYSSEY LONG TERM.
| Autor: | Robinson, Jennifer G., Farnier, Michel, Krempf, Michel, Bergeron, Jean, Luc, Gérald, Averna, Maurizio, Stroes, Eric S., Langslet, Gisle, Raal, Frederick J., Shahawy, Mahfouz El, Koren, Michael J., Lepor, Norman E., Lorenzato, Christelle, Pordy, Robert, Chaudhari, Umesh, Kastelein, John J. |
|---|---|
| Zdroj: | Circulation; 12/2/2014, Vol. 130 Issue 23, p2120-2120, 2/3p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|